SKQ Project
Science
Overview
History
Molecule
Oxidative stress
Anti-Ageing
Biotechnology
Overview
Mechanism of action
Safety
Ophthalmology
Inflammation
Neurodegeneration
Publications
Theory
Mechanism of Action
Immunology and inflammation
Neurodegeneration
Ophthalmology
Ischemia-related damage
Anti-ageing
Project
Summary
News
Contact Us
Mitotech EU
News
01/10/2016
results-of-skq1-us-phase-2-clinical-study-in-patients-with-dry-eye-syndrome-published-in-advances-in-therapy-journal
12/27/2015
results-of-mitotechs-multicenter-clinical-study-in-patients-with-dry-eye-syndrome-published-in-advances-in-therapy-journal
04/23/2015
mitotech-announces-phase-2-data-showing-positive-effect-of-skq1-in-patients-with-dry-eye-syndrome
04/21/2014
mitotech-s.a.-announces-the-initiation-of-phase-ii-clinical-trial-in-dry-eye-patients-utilizing-the-controlled-adverse-environment
05/16/2012
mitotech-russia-received-approval-for-marketing-visomitin-in-russia
01/12/2012
mitotech-europe-initiated-pre-clinical-program-for-skq1-compound-in-the-us
09/01/2010
mitotech-russia-successfully-completed-phase-i-clinical-trial-of-visomitin-in-russia